Ex-Drug Co. CEO's Actions Merit $1M FBAR Penalty, US Says

By David Hansen · April 29, 2019, 7:17 PM EDT

A pharmaceutical company's former chief executive officer acted recklessly when he failed to disclose a foreign bank account worth $2 million, warranting a stiffer penalty of almost $1 million, the U.S....

To view the full article, register now.